Stocks Hitting 52-Week Lows

NQ Mobile

shares reached a new 52-week low of $4.45 after the company announced certain changes to its Board of Directors and provided a status update on its 2013 annual audit. Regado Biosciences

shares touched a new 52-week low of $2.90 following the announcement of halt of patient enrollment in REGULATE-PCI trial. Wedbush downgraded Regado Biosciences from Outperform to Underperform. MELA Sciences

shares reached a new 52-week low of $0.303 after the company approved a one-for-ten reverse stock split of the common stock. Globeimmune

shares tumbled 4.71% to touch a new 52-week low of $10.53. Globeimmune has a 52-week high of $12.14.